Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 14 Feb 2025

Role of MLIP in burn-induced sepsis and insights into sepsis-associated cancer progression

in Cancer Immunity and Immunotherapy

Zhiwei Li
Qian Wang
Yezi Liu
Shuting Yang
Jin Zhao
Changdong Wu
Changmin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540998

122 views

Mini Review

Accepted on 13 Feb 2025

Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy

in Cancer Immunity and Immunotherapy

Hong Jin
Xinyue Meng
Feng Jianwei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560393

Original Research

Accepted on 13 Feb 2025

Disitamab Vedotin vs. Gemcitabine-Cisplatin Regimen with Immunotherapy: A Comparative Analysis of Efficacy and Safety in Muscle-Invasive Bladder Cancer

in Cancer Immunity and Immunotherapy

Chuanao Zhang
Yanhang Yu
Qi Zhou
Jun Ouyang
Zhiyu Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1549647

Original Research

Published on 13 Feb 2025

Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Juan Xu
Zihao You
Zhongping Zhu
Min Liu
Zheng Zhang
Panpan Xu
Juanjuan Dong
Yuting Huang
Chao Wang
Haotian Qin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1520070

289 views

Original Research

Published on 13 Feb 2025

A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes

in Cancer Immunity and Immunotherapy

Zhuoqi Li
Ling Chen
Zhigang Wei
Hongtao Liu
Lu Zhang
Fujing Huang
Xiao Wen
Yuan Tian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1518102

260 views

Original Research

Published on 13 Feb 2025

Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration

in Cancer Immunity and Immunotherapy

Xinyue Shi
Jingyu Zang
Qi Gu
Mengmeng Zhang
Handi Sun
Lijun Yang
Jiahui Cheng
Ruonan Wang
Han Mao
Aitong Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1480771

371 views

Review

Published on 13 Feb 2025

Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review

in Cancer Immunity and Immunotherapy

Yuchun Jiang
Qing Tao
Xuehan Qiao
Yufei Yang
Chen Peng
Miao Han
Kebin Dong
Wei Zhang
Min Xu
Deqiang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1508730

227 views

Systematic Review

Published on 13 Feb 2025

Evaluating the efficacy and safety of immune checkpoint inhibitors in first and second-line treatments for recurrent and metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis of RCTs with a focus on PD-L1 expression

in Cancer Immunity and Immunotherapy

Wei Chen
Qiance Wei
Tong Xiao
Jinghan Lai
Mengmeng Huang
Yueran Ma
Lili Zhang
Wenxin Xue
Shui Liu
Lichaoyue Sun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1508885

154 views

Original Research

Accepted on 12 Feb 2025

Yiqi Huayu Jiedu Decoction reduces colorectal cancer liver metastasis by promoting N1 neutrophil chemotaxis

in Cancer Immunity and Immunotherapy

Hua-Jian Zhou
Bai-Xiang Mu
Meng-Chao Wen
Qi Zhao
Yunxiang Li
Wen-Xuan Zhao
Hong-Ye Yin
Shuai Ren
Jin-Yong Zhou
Min Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530053

Mini Review

Accepted on 12 Feb 2025

Reprogramming Tumor-Associated Macrophages in Gastric Cancer: A Pathway to Enhanced Immunotherapy

in Cancer Immunity and Immunotherapy

Yibo He
Qianran Hong
Shi-liang Chen
Jiayi Zhou
Shengliang Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558091

Original Research

Accepted on 12 Feb 2025

The Key Role of DLX6 in Nasopharyngeal Carcinoma: Metastasis, Angiogenesis and Tumor Immune Mechanism

in Cancer Immunity and Immunotherapy

Yang Hanxuan
Zeng Ximing
Xiaochuan Chen
Sunqin Cai
Li Yi Li
Xu Wenqian
Lai Jinghua
Sufang Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1522580

Original Research

Accepted on 12 Feb 2025

Integration of Single-nuclei and Spatial Transcriptomics to Decipher Tumor Phenotype Predictive of Relapse-Free Survival in Wilms Tumor

in Cancer Immunity and Immunotherapy

Ran Yang
Lulu Xie
Rui Wang
Yi Li
Yifei Lu
Baihui Liu
Shuyang Dai
Shan Zheng
Kuiran Dong
Rui Dong

Frontiers in Immunology

doi 10.3389/fimmu.2025.1539897

General Commentary

Published on 12 Feb 2025

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of the Meet-Uro 15 study

in Cancer Immunity and Immunotherapy

Martina Catalano
Sara Elena Rebuzzi
Giuseppe Fornarini
Giandomenico Roviello

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555559

172 views

Original Research

Published on 12 Feb 2025

IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer

in Cancer Immunity and Immunotherapy

Stine Høvring Godsk
Caroline Maren Stengaard Jensen
Trine Vilsbøll Larsen
Johanne Ahrenfeldt
Kristine Raaby Gammelgaard
Martin Roelsgaard Jakobsen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1525083

388 views

Original Research

Published on 12 Feb 2025

Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myeloma

in Cancer Immunity and Immunotherapy

Eva Tranter
David Busch
Clarissa Heck
Igor Wolfgang Blau
Axel Nogai
Phillip Schiele
Christian Meisel
Lars Bullinger
Marco Frentsch
Il-Kang Na

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532645

382 views

Original Research

Published on 12 Feb 2025

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy

in Cancer Immunity and Immunotherapy

Meifeng Luo
Huiting Wei
Moqin Qiu
Cuiyun Su
Ruiling Ning
Shaozhang Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1473962

247 views

Navigation group

Articles

Role of MLIP in burn-induced sepsis and insights into sepsis-associated cancer progression

Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy

Disitamab Vedotin vs. Gemcitabine-Cisplatin Regimen with Immunotherapy: A Comparative Analysis of Efficacy and Safety in Muscle-Invasive Bladder Cancer

Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma

A novel classification method for LUAD that guides personalized immunotherapy on the basis of the cross-talk of coagulation- and macrophage-related genes

Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration

Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review

Evaluating the efficacy and safety of immune checkpoint inhibitors in first and second-line treatments for recurrent and metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis of RCTs with a focus on PD-L1 expression

Yiqi Huayu Jiedu Decoction reduces colorectal cancer liver metastasis by promoting N1 neutrophil chemotaxis

Reprogramming Tumor-Associated Macrophages in Gastric Cancer: A Pathway to Enhanced Immunotherapy

The Key Role of DLX6 in Nasopharyngeal Carcinoma: Metastasis, Angiogenesis and Tumor Immune Mechanism

Integration of Single-nuclei and Spatial Transcriptomics to Decipher Tumor Phenotype Predictive of Relapse-Free Survival in Wilms Tumor

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of the Meet-Uro 15 study

IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer

Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myeloma

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy